Catalog |
name |
Description |
price |
R-R-2261 |
Pemetrexed CAS No.137281-23-3 |
Pemetrexed (LY231514)/CAS No.137281-23-3 is an antifolate, the Ki values of the pentaglutamate of Pemetrexed (LY231514) are 1.3, 7.2, and 65 nM for inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively. |
price> |
R-C-764 |
CZC54252 CAS:1191911-27-9 |
CZC54252 is a highly effective inhibitor of LRRK2.Its IC50 values for wild-type LRRK2 and mutant G2019S LRRK2 are 1.28 and 1.85 nm,respectively. |
price> |
R-C-1078 |
GSK2578125A CAS:1285515-21-0 |
GSK2578215A is a potent and highly selective LRRK2 inhibitor,which exhibits IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant. |
price> |
R-C-1121 |
SKF-86002 CAS:72873-74-6 |
SKF-86002 is an orally active p38 MAPK inhibitor,with anti-inflammatory,anti-arthritic and analgesic activities.SKF-86002 inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. |
price> |
R-C-1124 |
PF06447475 CAS:1527473-33-1 |
PF06447475 is a highly potent,selective,brain penetrant,and in vivo active LRRK2 kinase inhibitor.Leucine rich repeat kinase 2(LRRK2)has been genetically linked to Parkinson disease(PD)by genome-wide association studies(GWAS).The most common LRRK2 mutation,G2019S,which is relatively rare in the total population,gives rise to increased kinase activity.As such,LRRK2 kinase inhibitors are potentially useful in the treatment of PD. |
price> |
R-C-1190 |
LRRK2-IN-1 CAS:1234480-84-2 |
LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC50 of 6 nM and 13 nM for LRRK2(G2019S)and LRRK2(WT),respectively. |
price> |
R-C-1237 |
Spautin-1 CAS:1262888-28-7 |
Spautin-1 is a novel autophagy inhibitor,IM inhibited the growth of K562 cells with IC50 of 1.03μM.In contrast,co-treatment with Spautin-1 increased IM-induced inhibition of cell viability with IC50 of 0.45 μM. |
price> |
R-C-1286 |
SR9009 CAS:1379686-30-2 |
SR9009 is a rev-ErbA agonist.It increases the constitutive repression of genes regulated by Rev-ErbA with a half-maximum inhibitory concentration(IC50)=670 nM for Rev-ErbAαand IC50=800 nM for Rev-ErbAβ. |
price> |
R-C-1298 |
SBI0206965 CAS:1884220-36-3 |
SBI0206965 is a potent and selective autophagy Kinase ULK1 Inhibitor.Many tumors become addicted to autophagy for survival,suggesting inhibition of autophagy as a potential broadly applicable cancer therapy.SBI-0206965 is a highly selective ULK1 kinase inhibitor in vitro and suppressed ULK1-mediated phosphorylation events in cells,regulating autophagy and cell survival. |
price> |
R-C-1332 |
JH-II127 CAS:1700693-08-8 |
JH-II-127 is a highly potent,selective,and brain penetrant LRRK2 inhibitor,with IC50 of 6.6 nM,2.2 nM,47.7 nM for LRRK2-wild-type,LRRK2-G2019S,LRRK2-A2016T. |
price> |